Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001)

NCT03326986 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Cancer

Interventions

DRUG: MK-7252
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC